FX Frapaise (Xavier) holds a MD from the University of Paris and brings on board over 40 years’ experience in the Pharma Industry (Sanofi, Abbott, Bayer, Merck, Gruenenthal as well as in several start-ups) in different roles such as Board Member, VP R&D and Medical Affairs, CMO, CSO, and CEO.He has a degree in statistics and Business (INSEAD).
He has an extensive experience of international drug development (phase I to IV), and interaction with the FDA/EMA. One major focus of his experience is in the field of biosimilars development supporting companies such as Pfenex, Boehringer-Ingelheim, Merck KGaA, MundiPharma, and Prestige BIO